Literature DB >> 18975280

Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution.

Elisabetta Buscarini, Guido Manfredi, Alessandro Zambelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975280     DOI: 10.1002/lt.21656

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

1.  Bevacizumab treatment in hereditary hemorrhagic teleangiectasia.

Authors:  Sebastian Föllner; Michael Ibe; Jens Schreiber
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

2.  Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.

Authors:  Elisabetta Buscarini; Gioacchino Leandro; Dario Conte; Cesare Danesino; Erica Daina; Guido Manfredi; Guido Lupinacci; Gianfranco Brambilla; Fernanda Menozzi; Federico De Grazia; Pietro Gazzaniga; Giuseppe Inama; Roberto Bonardi; Pasquale Blotta; Pierangelo Forner; Carla Olivieri; Annalisa Perna; Maurizio Grosso; Giacomo Pongiglione; Edoardo Boccardi; Fabio Pagella; Giorgio Rossi; Alessandro Zambelli
Journal:  Dig Dis Sci       Date:  2011-02-03       Impact factor: 3.199

Review 3.  Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.

Authors:  Antoni Riera-Mestre; Pau Cerdà; Yoelimar Carolina Guzmán; Adriana Iriarte; Alba Torroella; José María Mora-Luján; Jose Castellote; Amelia Hessheimer; Constantino Fondevila; Laura Lladó
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

4.  High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment.

Authors:  Lilian B Olsen; Anette D Kjeldsen; Mikael K Poulsen; Jens Kjeldsen; Annette D Fialla
Journal:  Orphanet J Rare Dis       Date:  2020-11-26       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.